Leila Seres

655 total citations
17 papers, 551 citations indexed

About

Leila Seres is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Leila Seres has authored 17 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Leila Seres's work include Cardiac Ischemia and Reperfusion (5 papers), PARP inhibition in cancer therapy (5 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Leila Seres is often cited by papers focused on Cardiac Ischemia and Reperfusion (5 papers), PARP inhibition in cancer therapy (5 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Leila Seres collaborates with scholars based in Hungary, Germany and United States. Leila Seres's co-authors include Ferenc Horkay, György Acsády, L. Selmeci, Olli Vuolteenaho, Heikki Ruskoaho, Réka Skoumal, Miklós Tóth, Balázs Sármán, Gábor Földes and István Szokodi and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Critical Care Medicine and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Leila Seres

16 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leila Seres Hungary 10 217 211 114 98 78 17 551
David Coquerel France 12 258 1.2× 243 1.2× 70 0.6× 157 1.6× 75 1.0× 24 499
H.‐J. Mest Germany 12 93 0.4× 141 0.7× 152 1.3× 68 0.7× 173 2.2× 61 559
И. М. Студнева Russia 16 238 1.1× 273 1.3× 152 1.3× 239 2.4× 45 0.6× 82 790
L. Bartula United States 16 70 0.3× 126 0.6× 47 0.4× 82 0.8× 32 0.4× 39 517
Entesar F. Amin Egypt 13 60 0.3× 73 0.3× 94 0.8× 21 0.2× 120 1.5× 15 583
F. B. Ubatuba United Kingdom 10 202 0.9× 83 0.4× 141 1.2× 89 0.9× 52 0.7× 15 573
Tomoko Gomi Japan 15 103 0.5× 80 0.4× 292 2.6× 25 0.3× 131 1.7× 35 640
Teresa Sousa Portugal 16 63 0.3× 97 0.5× 244 2.1× 28 0.3× 84 1.1× 46 665
Maria Cecília Jordani Brazil 8 55 0.3× 130 0.6× 37 0.3× 39 0.4× 24 0.3× 22 547
A. Ocetkiewicz Poland 8 517 2.4× 110 0.5× 190 1.7× 64 0.7× 106 1.4× 13 939

Countries citing papers authored by Leila Seres

Since Specialization
Citations

This map shows the geographic impact of Leila Seres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Seres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Seres more than expected).

Fields of papers citing papers by Leila Seres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Seres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Seres. The network helps show where Leila Seres may publish in the future.

Co-authorship network of co-authors of Leila Seres

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Seres. A scholar is included among the top collaborators of Leila Seres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Seres. Leila Seres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Szabó, Gábor, Leila Seres, Pál Soós, et al.. (2011). Tetrahydrobiopterin improves cardiac and pulmonary function after cardiopulmonary bypass☆. European Journal of Cardio-Thoracic Surgery. 40(3). 695–700. 10 indexed citations
2.
Veres, Gábor, Tamás Radovits, Leila Seres, et al.. (2010). Effects of inosine on reperfusion injury after cardiopulmonary bypass. Journal of Cardiothoracic Surgery. 5(1). 106–106. 8 indexed citations
3.
Selmeci, L., Leila Seres, Mária Székely, Pál Soós, & György Acsády. (2010). Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs. Clinical Chemistry and Laboratory Medicine (CCLM). 48(3). 379–382. 4 indexed citations
4.
Radovits, Tamás, Leila Seres, Domokos Gerő, et al.. (2007). Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction. Experimental Gerontology. 42(7). 676–685. 44 indexed citations
5.
Skoumal, Réka, István Szokodi, Jani Aro, et al.. (2007). Involvement of endogenous ouabain-like compound in the cardiac hypertrophic process in vivo. Life Sciences. 80(14). 1303–1310. 13 indexed citations
6.
Beller, Carsten J., Tamás Radovits, Leila Seres, et al.. (2006). Poly(ADP-ribose) polymerase inhibition reverses vascular dysfunction after γ-irradiation. International Journal of Radiation Oncology*Biology*Physics. 65(5). 1528–1535. 9 indexed citations
7.
Radovits, Tamás, Leila Seres, Domokos Gerő, et al.. (2006). The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction. Mechanisms of Ageing and Development. 128(2). 173–181. 46 indexed citations
8.
Selmeci, L., et al.. (2006). Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. Free Radical Research. 40(9). 952–958. 52 indexed citations
9.
Selmeci, L., et al.. (2005). Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique. Clinical Chemistry and Laboratory Medicine (CCLM). 43(3). 294–7. 71 indexed citations
10.
Ala‐Kopsala, Minna, Heikki Ruskoaho, Juhani Leppäluoto, et al.. (2005). Single Assay for Amino-Terminal Fragments of Cardiac A- and B-Type Natriuretic Peptides. Clinical Chemistry. 51(4). 708–718. 25 indexed citations
11.
Szabó, Gábor, Pál Soós, Leila Seres, Carsten J. Beller, & Alexander Juhász‐Nagy. (2005). Computer-assisted ventricular reduction surgery. International Congress Series. 1281. 779–782. 1 indexed citations
12.
Horkay, Ferenc, et al.. (2004). Effects of Experimental Diabetes on Endothelin-induced Ventricular Arrhythmias in Dogs. Journal of Cardiovascular Pharmacology. 44(Supplement 1). S380–S382. 2 indexed citations
13.
Seres, Leila, Pál Soós, Mária Székely, Ferenc Horkay, & L. Selmeci. (2004). Antioxidant capacity of the human pericardial fluid: does gender have a role?. Clinical Chemistry and Laboratory Medicine (CCLM). 42(8). 952–7.
14.
Szabó, Gábor, Pál Soós, Ulrike Heger, et al.. (2004). Mesenteric injury after cardiopulmonary bypass: Role of poly(adenosine 5′-diphosphate-ribose) polymerase*. Critical Care Medicine. 32(12). 2392–2397. 9 indexed citations
15.
Šóš, P., Ulrike Heger, Christa Flechtenmacher, et al.. (2004). INO-1001 A NOVEL POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR IMPROVES CARDIAC AND PULMONARY FUNCTION AFTER CRYSTALLOID CARDIOPLEGIA AND EXTRACORPORAL CIRCULATION. Shock. 21(5). 426–432. 34 indexed citations
16.
Földes, Gábor, Ferenc Horkay, István Szokodi, et al.. (2003). Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochemical and Biophysical Research Communications. 308(3). 480–485. 218 indexed citations
17.
Kiss, Orsolya, Béla Merkely, Tamás Szabó, et al.. (2000). Endothelin-A-Receptor Antagonist LU 135.252 Inhibits the Formation of Ventricular Arrhythmias Caused By Intrapericardial Infusion of Endothelin-1. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S317–S319. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Coquerel Breakdown of academic impact, for papers by H.‐J. Mest Breakdown of academic impact, for papers by И. М. Студнева Breakdown of academic impact, for papers by L. Bartula Breakdown of academic impact, for papers by Entesar F. Amin Breakdown of academic impact, for papers by F. B. Ubatuba Breakdown of academic impact, for papers by Tomoko Gomi Breakdown of academic impact, for papers by Teresa Sousa Breakdown of academic impact, for papers by Maria Cecília Jordani Breakdown of academic impact, for papers by A. Ocetkiewicz
Rankless by CCL
2026